Global Oncology Academy
The Global Oncology Academy (GOA) is an educational platform for physicians and other healthcare professionals involved in oncology. Its mission is to increase knowledge regarding the disease course of specific cancers and address key elements for successful management. The GOA series will also share the science around innovations in combination therapies, oncology strategies, and new developments.
For more information about GOA, visit www.globaloncologyacademy.org.
61-75 of 474

Menin Inhibitors in AML: Six Clinical Showdowns That Shape Real-World Practice
CME/CEMenin Inhibitors in AML: Six Clinical Showdowns That Shape Real-World Practice

Case Consult: Treatment Strategies for FRα-Positive Platinum-Resistant Ovarian Cancer
MinuteCE®Case Consult: Treatment Strategies for FRα-Positive Platinum-Resistant Ovarian Cancer

Case Consult: Personalizing First-Line Maintenance Therapy in Advanced Ovarian Cancer
MinuteCE®Case Consult: Personalizing First-Line Maintenance Therapy in Advanced Ovarian Cancer

Case Consult: Treatment Strategies for HER2-Positive Platinum-Resistant Ovarian Cancer
MinuteCE®Case Consult: Treatment Strategies for HER2-Positive Platinum-Resistant Ovarian Cancer

Case Consult: Targeting CDH6 in Platinum-Resistant Ovarian Cancer
MinuteCE®Case Consult: Targeting CDH6 in Platinum-Resistant Ovarian Cancer
- advertisement

Axatilimab’s Impact on cGVHD and Associated BOS
Project Oncology®Axatilimab’s Impact on cGVHD and Associated BOS

Real-World Outcomes with Axatilimab in cGVHD
Project Oncology®Real-World Outcomes with Axatilimab in cGVHD

Advanced Urothelial Carcinoma: Optimizing Second-Line Care
Project Oncology®Advanced Urothelial Carcinoma: Optimizing Second-Line Care

The Art of Treatment Sequencing in Advanced Urothelial Carcinoma
Project Oncology®The Art of Treatment Sequencing in Advanced Urothelial Carcinoma

Current Approaches to Advanced Urothelial Carcinoma
Project Oncology®Current Approaches to Advanced Urothelial Carcinoma
- advertisement

First-Line Treatment Considerations in Advanced Urothelial Carcinoma
Project Oncology®First-Line Treatment Considerations in Advanced Urothelial Carcinoma

Real-World Sacituzumab Govitecan Reinforces Benefit in mTNBC
On the Frontlines of Metastatic Breast CancerReal-World Sacituzumab Govitecan Reinforces Benefit in mTNBC

Urine RNA Panel Supports Less Invasive Bladder Cancer Surveillance
Project Oncology®Urine RNA Panel Supports Less Invasive Bladder Cancer Surveillance


































